HGF and chronic obstructive pulmonary disease: Furthermore, COPD LR-MSCs exhibit a reduced ability to produce hepatocyte growth factor (HGF) and FGF-10, rendering them unable to orchestrate appropriate alveolar repair mechanisms73 (Fig. 2C).